Brain Scientific Inc. (BRSF)
USD 0.75
(0.0%)
USD 0.75
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -7.93 Million USD | -5.44% |
| 2021 | -8.32 Million USD | -202.43% |
| 2020 | -2.75 Million USD | -184.06% |
| 2019 | -968.85 Thousand USD | 24.57% |
| 2018 | -1.28 Million USD | -41.97% |
| 2017 | -904.75 Thousand USD | -899.73% |
| 2016 | - USD | -180900.0% |
| 2015 | -50.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | - USD | -100.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q4 | 611.22 Thousand USD | 113.99% |
| 2022 Q3 | -4.36 Million USD | -119.46% |
| 2022 Q2 | -1.99 Million USD | -16.88% |
| 2022 Q1 | -1.7 Million USD | 65.59% |
| 2022 FY | - USD | -5.44% |
| 2021 FY | - USD | -202.43% |
| 2021 Q3 | -1.72 Million USD | -62.72% |
| 2021 Q4 | -4.95 Million USD | -187.4% |
| 2021 Q1 | -589.88 Thousand USD | -4.84% |
| 2021 Q2 | -1.05 Million USD | -79.49% |
| 2020 Q1 | -451.65 Thousand USD | -230.15% |
| 2020 Q3 | -464.14 Thousand USD | -31.36% |
| 2020 Q4 | -562.68 Thousand USD | -21.23% |
| 2020 FY | - USD | -184.06% |
| 2020 Q2 | -353.34 Thousand USD | 21.77% |
| 2019 FY | - USD | 24.57% |
| 2019 Q4 | -136.8 Thousand USD | 41.78% |
| 2019 Q3 | -234.96 Thousand USD | -20.38% |
| 2019 Q2 | -195.18 Thousand USD | 51.44% |
| 2019 Q1 | -401.9 Thousand USD | 0.41% |
| 2018 FY | - USD | -41.97% |
| 2018 Q1 | -277.17 Thousand USD | 7.25% |
| 2018 Q2 | -236.06 Thousand USD | 14.83% |
| 2018 Q3 | -367.66 Thousand USD | -55.74% |
| 2018 Q4 | -403.56 Thousand USD | -9.77% |
| 2017 Q3 | -229.62 Thousand USD | 21.67% |
| 2017 Q1 | -188.14 Thousand USD | -780.81% |
| 2017 Q2 | -293.16 Thousand USD | -55.82% |
| 2017 Q4 | -298.85 Thousand USD | -30.15% |
| 2017 FY | - USD | -899.73% |
| 2016 Q2 | -24.53 Thousand USD | -19.38% |
| 2016 Q3 | -24.28 Thousand USD | 1.04% |
| 2016 Q4 | -21.36 Thousand USD | 12.03% |
| 2016 FY | - USD | -180900.0% |
| 2016 Q1 | -20.55 Thousand USD | -41008.0% |
| 2015 Q4 | -50.00 USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -2792.459% |
| IR-Med Inc. | -4.89 Million USD | -62.178% |
| Polarean Imaging plc | -11.19 Million USD | 29.131% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 1839.623% |
| Avitar, Inc. | -1.66 Million USD | -375.699% |
| AVITA Medical, Inc. | -39.56 Million USD | 79.949% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -581.592% |
| Össur hf. | 137.38 Million USD | 105.775% |
| Zecotek Photonics Inc. | -3.44 Million USD | -130.483% |
| QHSLab, Inc. | -91.29 Thousand USD | -8590.399% |
| Wellstar International, Inc. | -1.35 Million USD | -484.86% |
| Össur hf. | 137.38 Million USD | 105.775% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 181.171% |
| Escalon Medical Corp. | -58.46 Thousand USD | -13470.972% |
| Aurora Spine Corporation | -454.37 Thousand USD | -1646.063% |
| BrainsWay Ltd. | -2.31 Million USD | -243.303% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 15.413% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 243.685% |
| Vivos Inc. | -2.79 Million USD | -184.043% |
| MicroPort Scientific Corporation | -347.57 Million USD | 97.717% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -3913.195% |
| REMSleep Holdings, Inc. | -1.66 Million USD | -375.485% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -1993.851% |
| Nanomix Corporation | -8.13 Million USD | 2.531% |
| Theraclion SA | -2.05 Million USD | -286.863% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -1022.12% |
| Positron Corporation | -1.45 Million USD | -446.343% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | -360.758% |
| Lombard Medical, Inc. | -28.06 Million USD | 71.734% |
| ALR Technologies Inc. | -6.4 Million USD | -23.958% |
| Stratec SE | 39.91 Million USD | 119.877% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 7959.61% |
| Heart Tronics, Inc. | -14.85 Million USD | 46.599% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -6608.771% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 40.244% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 13.312% |
| VMS Rehab Systems, Inc. | -68.55 USD | -11573533.844% |
| Guided Therapeutics, Inc. | -3.12 Million USD | -153.798% |
| Ingen Technologies, Inc. | -8639.00 USD | -91736.162% |
| Odyssey Group International, Inc. | -2.13 Million USD | -271.069% |
| United American Healthcare Corporation | -59 Thousand USD | -13346.993% |
| ECGI Holdings, Inc. | -2.99 Million USD | -165.304% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -1160.957% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -1443.451% |
| Urologix, Inc. | -6.34 Million USD | -25.059% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -540.146% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -935.779% |
| SS Innovations International, Inc. | -20.37 Million USD | 61.063% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -3460.631% |
| Smith & Nephew plc | 1 Billion USD | 100.791% |
| NIOX Group Plc | 11.07 Million USD | 171.636% |
| Fuse Medical, Inc. | 1.83 Million USD | 532.281% |
| Broncus Holding Corporation | -25.19 Million USD | 68.515% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 15.517% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -43018.076% |